| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 伟思医疗 | 40.33 | 减持 | 流通A股 | 0.42% | 2025-06-30 |
| 2 | 伟思医疗 | 58.6 | 减持 | 流通A股 | 0.61% | 2025-03-31 |
| 3 | 伟思医疗 | 61.22 | 减持 | 流通A股 | 0.64% | 2024-12-31 |
| 4 | 伟思医疗 | 66.99 | 减持 | 流通A股 | 0.7% | 2024-09-30 |
| 5 | 伟思医疗 | 69.27 | 增持 | 流通A股 | 0.72% | 2024-06-30 |
| 6 | 伟思医疗 | 50.36 | 未变 | 流通A股 | 0.73% | 2024-03-31 |
| 7 | 伟思医疗 | 50.36 | 减持 | 流通A股 | 0.73% | 2023-12-31 |
| 8 | 伟思医疗 | 50.76 | 减持 | 流通A股 | 0.74% | 2023-11-09 |
| 9 | 伟思医疗 | 51.26 | 减持 | 流通A股 | 0.75% | 2023-09-30 |
| 10 | 伟思医疗 | 51.52 | 减持 | 流通A股 | 0.75% | 2023-06-30 |
| 11 | 伟思医疗 | 70.49 | 减持 | 流通A股 | 1.03% | 2023-03-31 |
| 12 | 伟思医疗 | 76.89 | 减持 | 流通A股 | 1.12% | 2022-12-31 |
| 13 | 伟思医疗 | 79.39 | 减持 | 流通A股 | 1.16% | 2022-09-30 |
| 14 | 伟思医疗 | 84.29 | 减持 | 流通A股 | 1.23% | 2022-06-30 |
| 15 | 伟思医疗 | 91.59 | 未变 | 流通A股 | 1.34% | 2022-04-11 |
| 16 | 伟思医疗 | 91.59 | 减持 | 流通A股 | 1.34% | 2022-03-31 |
| 17 | 伟思医疗 | 92.9 | 减持 | 流通A股 | 1.36% | 2021-12-31 |
| 18 | 伟思医疗 | 112.61 | 减持 | 流通A股 | 1.65% | 2021-09-30 |
| 19 | 伟思医疗 | 126.00 | 新进 | 1.84% | 2021-06-30 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 伟思医疗 | 40.33 | 减持 | 境内法人股 | 0.421% | 2025-06-30 |
| 2 | 伟思医疗 | 58.6 | 减持 | 境内法人股 | 0.612% | 2025-03-31 |
| 3 | 伟思医疗 | 61.22 | 减持 | 境内法人股 | 0.639% | 2024-12-31 |
| 4 | 伟思医疗 | 66.99 | 减持 | 境内法人股 | 0.7% | 2024-09-30 |
| 5 | 伟思医疗 | 69.27 | 增持 | 境内法人股 | 0.723% | 2024-06-30 |
| 6 | 伟思医疗 | 50.36 | 未变 | 境内法人股 | 0.734% | 2024-03-31 |
| 7 | 伟思医疗 | 50.36 | 减持 | 境内法人股 | 0.734% | 2023-12-31 |
| 8 | 伟思医疗 | 50.76 | 减持 | 流通A股 | 1.27% | 2023-11-09 |
| 9 | 伟思医疗 | 51.26 | 减持 | 境内法人股 | 0.747% | 2023-09-30 |
| 10 | 伟思医疗 | 51.52 | 减持 | A股 | 2.08% | 2023-06-30 |
| 11 | 伟思医疗 | 70.49 | 减持 | 境内法人股 | 2.846% | 2023-03-31 |
| 12 | 伟思医疗 | 76.89 | 减持 | 境内法人股 | 3.104% | 2022-12-31 |
| 13 | 伟思医疗 | 79.39 | 减持 | 境内法人股 | 3.206% | 2022-09-30 |
| 14 | 伟思医疗 | 84.29 | 减持 | 境内法人股 | 3.5% | 2022-06-30 |
| 15 | 伟思医疗 | 91.59 | 未变 | 境内法人股 | 3.847% | 2022-04-11 |
| 16 | 伟思医疗 | 91.59 | 减持 | 境内法人股 | 3.847% | 2022-03-31 |
| 17 | 伟思医疗 | 92.9 | 减持 | 境内法人股 | 3.902% | 2021-12-31 |
| 18 | 伟思医疗 | 112.61 | 新进 | 境内法人股 | 4.73% | 2021-09-30 |
![]() |
![]() |